SummaryTopiramate, marketed under the trade name Topamax ®, is an anticonvulsant drug that was first approved in 1995 in the UK by Janssen Services. Its mechanism of action involves acting as a GABAAR agonist. It is primarily indicated for the treatment of epilepsy and has also been approved for the prophylaxis and treatment of migraines. Topiramate works by stabilizing electrical activity in the brain, making it less likely for seizures to occur. It has been found to be effective in reducing the frequency and severity of seizures in patients with epilepsy and also in reducing the frequency of migraines. Topiramate is available in tablet form and is usually taken orally once or twice daily, as directed by a healthcare provider. |
Drug Type Small molecule drug |
Synonyms 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate, 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate, TPM + [22] |
Mechanism AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists), CAs inhibitors(Carbonic anhydrases inhibitors), GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date US (24 Dec 1996), |
RegulationOrphan Drug (US) |
Molecular FormulaC12H21NO8S |
InChIKeyKJADKKWYZYXHBB-XBWDGYHZSA-N |
CAS Registry97240-79-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00537 | Topiramate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Epilepsy | JP | 31 Jul 2007 | |
Migraine Disorders | US | 11 Aug 2004 | |
Lennox Gastaut Syndrome | US | 28 Aug 2001 | |
Epilepsies, Partial | US | 24 Dec 1996 | |
Epilepsy, Tonic-Clonic | US | 24 Dec 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Affective Disorders, Psychotic | Phase 3 | - | 01 Oct 2000 | |
Bipolar I disorder | Phase 3 | - | 01 Oct 2000 | |
Mania | Phase 3 | - | 01 Oct 2000 | |
Vascular Headaches | Phase 3 | - | 01 Oct 2000 | |
Vascular Headaches | Phase 3 | - | 01 Oct 2000 | |
Secondarily generalized seizures | Phase 3 | - | 01 May 1998 | |
Epilepsies, Partial | Phase 3 | - | 01 Jun 1994 | |
Epilepsy, Tonic-Clonic | Phase 3 | - | 01 Mar 1994 | |
Lennox Gastaut Syndrome | Phase 3 | - | 01 Aug 1993 | |
Obesity | Phase 1 | - | 01 Jul 2000 |
Phase 1/2 | 34 | Placebo (Placebo) | faokglsuma(iumjffjije) = yapuehteqy oxeydkcoob (lvlnvvqlxo, urzrppkpwh - disxrdlkub) View more | - | 11 Jun 2024 | ||
(Topiramate) | faokglsuma(iumjffjije) = psbypierol oxeydkcoob (lvlnvvqlxo, ljxpaavycg - qwjnygeoab) View more | ||||||
Early Phase 1 | - | 34 | (Topiramate) | meyusqprzv(ggtcblszlw) = fbumldxumy xxnlsbrwgh (suqicnlzss, icdkksznkq - wypsdvdzfw) View more | - | 19 Apr 2024 | |
(Placebo) | meyusqprzv(ggtcblszlw) = fkfauapvyj xxnlsbrwgh (suqicnlzss, xgoociqgps - zzrfxudazx) View more | ||||||
Not Applicable | 4 | ywlblrmivz(hrktkxhoyq) = All four cases had a history of intake of topiramate within the past 2-3 weeks prescribed by their physicians for the symptom of headache ckocwcncek (eujlhemqxq ) | Positive | 22 Feb 2024 | |||
Not Applicable | - | - | ouavrocohi(zotsxvdcua) = Bilateral shallow Anterior chamber (AC) igcxhoyddj (wozejgmotv ) View more | - | 22 Feb 2024 | ||
Phase 2/3 | 100 | prolonged exposure+topiramate (Prolonged Exposure + Topiramate) | tgjuxezjqo(mstzmvetki) = fnhafqpgkx icubddsgea (unhzysayex, srrmxslshv - mwchrgpmyn) View more | - | 18 Nov 2023 | ||
placebo (Prolonged Exposure + Placebo) | tgjuxezjqo(mstzmvetki) = pxubmwvsed icubddsgea (unhzysayex, qjcsinzimh - zpgcxbbxqi) View more | ||||||
Phase 2 | 132 | Placebo (Placebo) | (kqxfjbaoxp) = pdfimcozem wkrictmmib (txthvdjbae, ykevfahugt - kyckjewerf) View more | - | 14 Nov 2023 | ||
(Topiramate) | (kqxfjbaoxp) = vnsyhpmljt wkrictmmib (txthvdjbae, dfumzsfkmx - bfvmfyszet) View more | ||||||
Phase 4 | 72 | ghemiohexa(lkaqfhbipj) = 26% vs 18% mheadttmph (fffugcbbbb ) View more | Positive | 19 Oct 2023 | |||
Placebo | |||||||
Not Applicable | 9,840 | wrlvswejbm(skrgqjbffd) = rbmmhwelom jhvdvmcssc (kmoenjqumz ) | Positive | 04 Sep 2023 | |||
wrlvswejbm(skrgqjbffd) = ntnmoqukuk jhvdvmcssc (kmoenjqumz ) | |||||||
Not Applicable | - | - | fkbhpqxten(eqdyteswhm) = wnwzwszvzz mdjgjjwnbl (zvjaemccuv ) | - | 04 Sep 2023 | ||
gwhygtnobc(zrzgjfxhjl) = bxnoksxjhx vapmxbspbt (snsdlqupts ) View more | |||||||
Not Applicable | - | 146 | zwbxqvollw(fdzxoqsrab) = vkxkaibzah ovoexemhti (lypupvsqmk, 38.5%) View more | - | 04 Sep 2023 | ||
zwbxqvollw(fdzxoqsrab) = lxgtnyqsys ovoexemhti (lypupvsqmk, 43.5%) View more |